NVP-BEP800: an orally bioavailable small molecule Hsp90 inhibitor with potent in vivo antitumor activity

被引：0
|
作者：
Jensen, Michael
Schoepfer, Joseph
Massey, Andrew
Brough, Paul
Brueggen, Josef
Schweitzer, Alain
Pfaar, Ulrike
Quadt, Corneiia
Drysdale, Martin
Chene, Patrick
Garcia-Echeverria, Carlos
机构：
[1] Novartis Inst Biomed Res, Basel, Switzerland
[2] Vernalis Ltd, Great Abington, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5632
引用
收藏
页数：1
相关论文
共 50 条
  • [1] NVP-BEP795 and NVP-BEP800: Novel, fragment derived orally bioavailable small molecule Hsp90 inhibitors with potent antitumor activity
    Massey, Andrew
    Brough, Paul
    Jensen, Michael
    Ruetz, Stephan
    Schoepfer, Joseph
    Workman, Paul
    Garcia-Echeverria, Carlos
    Drysdale, Martin
    CANCER RESEARCH, 2009, 69
  • [2] Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800
    Massey, Andrew J.
    Schoepfer, Joseph
    Brough, Paul A.
    Brueggen, Josef
    Chene, Patrick
    Drysdale, Martin J.
    Pfaar, Ulrike
    Radimerski, Thomas
    Ruetz, Stephan
    Schweitzer, Alain
    Wood, Mike
    Garcia-Echeverria, Carlos
    Jensen, Michael Rugaard
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (04) : 906 - 919
  • [3] Preclinical anti-myeloma activity of the novel Hsp90 ATPase inhibitor NVP-BEP800
    Stuehmer, Thorsten
    Jensen, Michael
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    Bargou, Ralf
    CANCER RESEARCH, 2009, 69
  • [4] Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800
    Stuehmer, Thorsten
    Chatterjee, Manik
    Grella, Evelyn
    Seggewiss, Ruth
    Langer, Christian
    Mueller, Sabine
    Schoepfer, Joseph
    Garcia-Echeverria, Carlos
    Quadt, Cornelia
    Jensen, Michael R.
    Einsele, Hermann
    Bargou, Ralf C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (03) : 319 - 327
  • [5] NVP-AUY922:: A novel small molecule HSP90 inhibitor with potent in vivo antitumor efficacy
    Jensen, Michael Rugaard
    Schoepfer, Joseph
    Radimersky, Thomas
    Massey, Andrew
    Brueggen, Josef
    Schweitzer, Alain
    Pfaar, Ulrike
    Ruetz, Stephan
    Guy, Chantal
    Buckler, Alan
    Schnell, Christian
    Cozens, Robert
    Brough, Paul
    Drysdale, Martin
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    Chene, Patrick
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3521S - 3521S
  • [6] NVP-BEP800/VER-82576: A potent orally active Hsp90 chaperone inhibitor evolved by SBDD from Vernalis fragment ("SeeDs") hits and in silico screening hits
    Davies, Nicholas G. M.
    Barril, X.
    Drysdale, M. J.
    Brough, P. A.
    Eccles, S. A.
    Dymock, B.
    Garcia-Echeverria, Carlos
    Massey, A.
    Radimerski, Thomas
    Raynaud, F. I.
    Jensen, M. Rugaard
    Schoepfer, J.
    Sharp, S. Y.
    Workman, P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [7] NVP-AUY922:: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
    Jensen, Michael Rugaard
    Schoepfer, Joseph
    Radimerski, Thomas
    Massey, Andrew
    Guy, Chantale T.
    Brueggen, Josef
    Quadt, Cornelia
    Buckler, Alan
    Cozens, Robert
    Drysdale, Martin J.
    Garcia-Echeverria, Carlos
    Chene, Patrick
    BREAST CANCER RESEARCH, 2008, 10 (02)
  • [8] NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
    Michael Rugaard Jensen
    Joseph Schoepfer
    Thomas Radimerski
    Andrew Massey
    Chantale T Guy
    Josef Brueggen
    Cornelia Quadt
    Alan Buckler
    Robert Cozens
    Martin J Drysdale
    Carlos Garcia-Echeverria
    Patrick Chène
    Breast Cancer Research, 10
  • [9] NVP-BEP800 / VER-82576: A potent orally active Hsp90 chaperone inhibitor evolved by SBDD from Vernalis fragment (\#8220;SeeDs\#8221;) hits and in silco screening hits
    Brough, Paul
    Massey, Andrew
    Jensen, Michael
    Schoepfer, Joseph
    Barril, Xavier
    Hubbard, Rod
    Dymock, Brian
    Surgenor, Alan
    Wright, Lisa
    Cozens, Bob
    Eccles, Sue
    Sharp, Swee
    Raynaud, Flo
    Workman, Paul
    Garcia-Echeverria, Carlos
    Wood, Mike
    Drysdale, Martin
    CANCER RESEARCH, 2009, 69
  • [10] Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitize tumor cell lines under acute hypoxia
    Blassl, C.
    Djuzenova, C. S.
    Katzer, A.
    Tripp, C.
    Roloff, K.
    Bernhard, M.
    Flentje, M.
    Jensen, M. R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 74 - 74
12345